You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國家醫保局:目前獲批上市國產新冠藥已全部被納入醫保支付範圍
國家醫保局醫藥管理司負責人表示,國家醫保局於1月30日印發文件,要求各省級醫療保障部門按照《國家醫保局財政部國家衛生健康委國家疾控局關於實施「乙類乙管」後優化新型冠狀病毒感染患者治療費用醫療保障相關政策的通知》(醫保發〔2023〕1號)要求,將氫溴酸氘瑞米德韋片、先諾特韋片/利托那韋片組合包裝2個藥品臨時性納入本省份基本醫保基金支付範圍,支付至今年3月31日。 目前,獲批上市的國產新冠治療用藥已全部被納入醫保支付範圍。其中,中藥「三藥三方」和阿茲夫定片已正式納入醫保藥品目錄,氫溴酸氘瑞米德韋片、先諾特韋片/利托那韋片組合包裝等藥品臨時性納入醫保支付範圍。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account